JG
MRNA icon

Jefferies Group’s Moderna MRNA Stock Holding History

Jefferies Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,000
Closed -$12.7M – 1803
2021
Q4 		$12.7M Hold
50,000
– – 0.07% 219
2021
Q3 		$19.2M Hold
50,000
– – 0.14% 130
2021
Q2 		$11.7M Hold
50,000
– – 0.07% 237
2021
Q1 		$6.55M Sell
50,000
-38,500
-44% -$5.58M 0.06% 295
2020
Q4 		$9.25M Buy
88,500
+44,800
+103% +$4.53M 0.07% 237
2020
Q3 		$3.09M Buy
43,700
+10,500
+32% +$732K 0.03% 418
2020
Q2 		$2.13K Buy
+33,200
New +$1.82M 0.03% 527
2019
Q4 		– Sell
-72,000
Closed -$1.15M – 2824
2019
Q3 		$1.15M Hold
72,000
– – 0.01% 1433
2019
Q2 		$1.05M Buy
+72,000
New +$1.55M 0.01% 1264

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jefferies Group's MRNA Position: Q3 2022 in Review

Jefferies Group sold out of Moderna (MRNA) in Q3 2022, closing a stake of 3,752 shares — an estimated $536K sold.

Jefferies Group first reported a position in MRNA in Q2 2019 and held it in 10 quarters. The position peaked at $35M in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Jefferies Group reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Jefferies Group sold 3,752 Moderna shares in Q3 2022, an estimated $536K.
  • Jefferies Group first reported a position in Moderna in Q2 2019 and held it in 10 quarters.
  • Jefferies Group's Moderna position peaked at $35M in Q3 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.